Which cognitive biases were evident in Johnson & Johnson's failure?

5 bias patterns are documented in this case, led by Status Quo Bias. The full set: Status Quo Bias, Confirmation Bias, Loss Aversion, Selective Perception, Cognitive Misering. Each is mapped to Decision Intel's 22-bias R²F taxonomy with stable IDs and academic citations.

Did these cognitive biases cause Johnson & Johnson's failure?

Decision Intel identifies reasoning-risk indicators correlated with poor outcomes — it does not claim to establish causation. That honesty is the procurement weapon: a CSO can defend a score that names the risk indicators a committee should pressure-test, not one that pretends to prove the cause. Status Quo Bias and the other documented patterns were detectable in the reasoning before the outcome was known; whether they caused it is a question no audit can settle — too many other factors (market, timing, execution) are in play. A reasoning audit names the risk indicators a committee should pressure-test, not a verdict it should accept.

What is Decision Intel's reasoning audit?

Decision Intel runs a Recognition-Rigor Framework (R²F) audit on strategic memos, detecting cognitive biases from a 22-bias canonical taxonomy and producing a Decision Quality Index (DQI) score. The audit produces a hashed, tamper-evident Decision Provenance Record (DPR) suitable for audit-committee review.

All case studies

FailureHealthcare1970

Johnson & Johnson

Johnson & Johnson Talc Powder Litigation

Estimated impact: $3.9B

F33

Decision Quality Index (simulated)

Critical · 5 biases detected, 1 toxic combinations

J&J faced tens of thousands of lawsuits alleging its talcum powder products contained asbestos and caused ovarian cancer. Internal documents revealed the company was aware of potential contamination as early as the 1970s but chose to maintain the product line rather than switch to corn starch alternatives.

Decision context

Whether to reformulate or discontinue talc-based baby powder products after internal testing detected trace asbestos contamination and epidemiological studies suggested cancer risk.

Deep hindsight-stripped analysis coming soon. This case is part of our ongoing backfill to reconstruct what was flaggable in the record at decision time. The summary and bias profile below are drawn from primary sources.

Decision anatomy

Monetary stakes

High

Dissent suppressed

Time pressure

None

Unanimous consensus

Decision participants

Dissent encouraged

External advisors

Iterative process

Red = risk factor present · Green = protective factor present

Biases present in the decision

★Status Quo Bias

critical

Confirmation Bias

high

Loss Aversion

medium

Selective Perception

medium

Cognitive Misering

medium

★ Primary driver · Severity estimated from bias type and decision outcome

3D Decision Knowledge Graph

Johnson & Johnson · 5 biases, 1 toxic combination

Drag to rotate · Scroll to zoom · Click to explore

Decision

Critical

High

Medium

Toxic

Bias Intensity Profile

Severity × confidence across 5 detected biases

Toxic combinations

!Status Quo Lock

Loss aversion combined with status quo bias makes even clearly beneficial change feel impossible.

The curated library this case sits in

Across all 155 curated case studies in our library, by documented outcome:

123

documented failures

partial / mixed

documented successes

The library is curated toward documented failures, so this split describes the library, not the base rate of deals. The case above is one row in it.

■ Failure■ Partial■ Success

Lessons learned

Status quo bias in legacy product lines can persist for decades when reformulation costs seem to outweigh uncertain litigation risk.
Confirmation bias in internal safety reviews leads to dismissing unfavorable findings rather than acting on precautionary principles.
Loss aversion around an iconic product brand can override scientific evidence and basic consumer safety obligations.

Source: Reuters investigation, "Johnson & Johnson Knew for Decades that Asbestos Lurked in Its Baby Powder" (2018) (News Investigation)

Pilot slots available

These patterns were flaggable in Johnson & Johnson's own record — before the outcome.

See the full reasoning audit we ran — no login, no card. Then run the same audit on a deal you have already closed.

See a live audit · no login Audit a deal of your own

Or leave your email, we'll run the audit on a deal of your choosing and send the readout within a business day.

Audit your own decision

Workflows that fire on decisions like Johnson & Johnson’s

The same Recognition-Rigor Framework that documents this case audits memos in the same shape — before the outcome forces the lesson.

For CSOs and Heads of Strategic Planning

Strategic memo audit

Audit a strategic memo for cognitive bias and forecast errors before the board sees it.

Audit a strategic memo

For any high-stakes decision, before commitment

Decision pre-mortem

Run a structured pre-mortem before the decision is final — surface failure modes the room cannot see from the inside.

Run a pre-mortem

For CSOs and CEOs presenting to a board

Board deck pre-presentation audit

Audit a board deck before the presentation — predict the toughest questions the room will ask.

Audit your board deck

See the full audit-tool surface.

Related cases in Healthcare

Failure2017

Deutsche Bank

Deutsche Bank Mirror Trading Scandal

Catastrophic failure2010

DePuy Orthopaedics (Johnson & Johnson)

DePuy ASR Hip Implant Recall

Catastrophic failure1975

Eastman Kodak

Kodak Digital Camera Decision

Catastrophic failure2007

Nokia

Nokia Smartphone Market Collapse

The curated library this case sits in

Across all 155 curated case studies in our library, by documented outcome:

123

documented failures

partial / mixed

documented successes

The library is curated toward documented failures, so this split describes the library, not the base rate of deals. The case above is one row in it.

■ Failure■ Partial■ Success

Lessons learned

Status quo bias in legacy product lines can persist for decades when reformulation costs seem to outweigh uncertain litigation risk.

Confirmation bias in internal safety reviews leads to dismissing unfavorable findings rather than acting on precautionary principles.

Loss aversion around an iconic product brand can override scientific evidence and basic consumer safety obligations.